Yang Li

Yang Li

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2013 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
PDF file
YCY. M. Chen
Y. M. Chen
YLYang Li
Yang Li
It is unclear whether exercise training is effective and safe for elderly patients with chronic heart failure (CHF). The purpose of this meta-analysis was to systematically analyse the completed trials assessing the safety and efficacy of exercise training in elderly patients with heart failure. We searched electronic databases up to September 2012 for randomised controlled trials (RCTs) evaluating exercise training in the elderly heart failure patients (≥ 60 years). The safety and efficacy of exercise training were assessed by all-cause mortality, hospitalisations, 6-min walking distance (6MWD), peakVO2 and/or health-related quality of life (HRQoL). Seven prospective RCTs were included with a total of 530 patients, and the patients' mean age ranged from 70 to 81 years. The majority were male, low-to-medium risk and New York Heart Association class II and III with a left ventricular ejection fraction of < 45%. Exercise training increased the 6MWD significantly by 50.05 m (95% CI: 28.37-71.73) and improved generic HRQoL (95% CI: 0.06-0.18). There was no significant difference in mortality, hospitalisations, peakVO2 and disease-specific HRQoL between exercise group and control group. In elderly CHF patients (mean age 70-81), exercise training increase 6MWD and improve generic HRQoL, but has no effects on mortality, hospitalisations, peakVO2 and disease-specific HRQoL. The long-term efficacy and safety of exercise training in elderly heart failure patients require further study based on large and rational-designed controlled clinical trials.

29 June 2022 in BMC Medicine
Verified
Journal Article
Open access
PDF file
MZMaoxiang Zhao
Maoxiang Zhao
LSLulu Song
Lulu Song
QZQianqian Zhao
Qianqian Zhao
YCYating Chen
Yating Chen
BLBin Li
Bin Li
YLYang Li
Yang Li
Background: Although obesity has been associated with risk of atrial fibrillation (AF), the associations of variability of obesity measures with AF risk are uncertain, and longitudinal studies among Chinese population are still lacking. We aimed to evaluate the impacts of obesity and variability of body mass index (BMI) and waist circumference (WC) on the risk of atrial fibrillation (AF) in a large Chinese cohort study. Methods: A total of 44,135 participants of the Kailuan Study who were free of cancer and cardiovascular disease and underwent three consecutive surveys from 2006 to 2010 were followed for incident AF until 2020. Average BMI and WC over time and variability were calculated. Cox proportional hazards regression models were used to assess hazard ratios (HRs) and 95% confidence intervals (CIs) for the associations of obesity and variability in BMI and WC with AF risk. Results: During a mean follow-up of 9.68 years, there were 410 cases of incident AF. In multivariable-adjusted models, compared with normal BMI/WC, individuals with general obesity and abdominal obesity had increased risk of AF, with corresponding HRs of 1.73 (95% CI: 1.31–2.30) and 1.38 (95% CI: 1.11–1.60), respectively. The short-term elevation in AF risk persisted for the obese even after adjustment for updated biologic intermediaries and weight. Variability in BMI and WC were not associated with the risk of AF. The restricted cubic spline models indicated significant linear relationships between levels of WC and BMI and risk of AF. Conclusions: Elevated levels of BMI and WC were associated with an increased risk of AF, whereas variability in BMI and WC were not. Therefore, achieving optimal levels of BMI and WC could be valuable in AF prevention.

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
CLChuanbin Liu
Chuanbin Liu
JBJing Bai
Jing Bai
QDQing Dan
Qing Dan
XYXue Yang
Xue Yang
KLKun Lin
Kun Lin
YLYang Li
Yang Li
The incidence of atrial fibrillation (AF) increases with age, and telomere length gradually shortens with age. However, whether telomere length is related to AF is still inconclusive, and the exact mechanism by which aging causes the increased incidence of AF is still unclear. We hypothesize that telomere length is correlated with aging‐related AF and that mitochondrial dysfunction plays a role in this. This research recruited 96 elderly male patients with AF who were admitted to the Second Medical Center of Chinese PLA General Hospital from April to October 2018. After matching by age and gender, 96 non‐AF elderly male patients who were admitted to the hospital for physical examination during the same period were selected as controls. Anthropometric, clinical, and laboratory analyses were performed on all subjects. The mitochondrial membrane potential (MMP) of peripheral blood leukocytes was detected as the indicator of mitochondrial function. Compared with the control group, the leukocyte telomere length (LTL) was significantly shorter (P < 0.001), and the level of PGC‐1α in serum was significantly lower in AF patients. Additionally, in subjects without any other diseases, the AF patients had lower MMP when compared with the control. Multivariate logistic regression confirmed that LTL (OR 0.365; 95% CI 0.235‐0.568; P < 0.001) and serum PGC‐1α (OR 0.993; 95% CI 0.988‐0.997; P = 0.002) were inversely associated with the presence of AF. In addition, ROC analysis indicated the potential diagnostic value of LTL and serum PGC‐1α with AUC values of 0.734 and 0.633, respectively. This research concludes that LTL and serum PGC‐1α are inversely correlated with the occurrence of aging‐related AF and that mitochondrial dysfunction plays a role in this.

1 January 2014 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
XYXu Yan
Xu Yan
JTJinwen Tian
Jinwen Tian
HWHongjin Wu
Hongjin Wu
YLYuna Liu
Yuna Liu
JRJianxun Ren
Jianxun Ren
SWShengqi Wang
Shengqi Wang
Aim. To investigate the effect of Ginsenoside Rb1 (GS‐Rb1) on hypoxia/ischemia (H/I) injury in cardiomyocytes in vitro and the mitochondrial apoptotic pathway mediated mechanism. Methods. Neonatal rat cardiomyocytes (NRCMs) for the H/I groups were kept in DMEM without glucose and serum, and were placed into a hypoxic jar for 24 h. GS‐Rb1 at concentrations from 2.5 to 40 µM was given during hypoxic period for 24 h. NRCMs injury was determined by MTT and lactate dehydrogenase (LDH) leakage assay. Cell apoptosis, ROS accumulation, and mitochondrial membrane potential (MMP) were assessed by flow cytometry. Cytosolic translocation of mitochondrial cytochrome c and Bcl‐2 family proteins were determined by Western blot. Caspase‐3 and caspase‐9 activities were determined by the assay kit. Results. GS‐Rb1 significantly reduced cell death and LDH leakage induced by H/I. It also reduced H/I induced NRCMs apoptosis induced by H/I, in accordance with a minimal reactive oxygen species (ROS) burst. Moreover, GS‐Rb1 markedly decreased the translocation of cytochrome c from the mitochondria to the cytosol, increased the Bcl‐2/ Bax ratio, and preserved mitochondrial transmembrane potential (ΔΨm). Its administration also inhibited activities of caspase‐9 and caspase‐3. Conclusion. Administration of GS‐Rb1 during H/I in vitro is involved in cardioprotection by inhibiting apoptosis, which may be due to inhibition of the mitochondrial apoptotic pathway.

18 January 2021 in Frontiers in Physiology
Verified
Journal Article
Open access
JBJing Bai
Jing Bai
CLChuanbin Liu
Chuanbin Liu
PZPingjun Zhu
Pingjun Zhu
YLYang Li
Yang Li
Cardiovascular complication is one of the significant causes of death in diabetic mellitus (DM) in which diabetic cardiomyopathy, independent of hypertension, cardiac valvular disease, and coronary atherosclerosis, occupies an important position. Although the detailed pathogenesis of diabetic cardiomyopathy remains unclear currently, mitochondrial morphological abnormality and dysfunction were observed in diabetic cardiomyopathy animal models according to much research, suggesting that mitochondrial structural and functional impairment played an integral role in the formation of diabetic cardiomyopathy. Thus, we have summarized the effect of mitochondria on the process of diabetic cardiomyopathy, including abnormal mitochondrial morphology, mitochondrial energy metabolism disorder, enhanced mitochondrial oxidative stress, mitochondrial unbalanced calcium homeostasis, and mitochondrial autophagy. Based on the above mechanisms and the related evidence, more therapeutic strategies targeting mitochondria in diabetic cardiomyopathy have been and will be proposed to delay the progression of the disease.

1 September 2016 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
XCXi Chen
Xi Chen
YZYu Zhang
Yu Zhang
BXBin Xu
Bin Xu
ZCZhongqi Cai
Zhongqi Cai
LWLin Wang
Lin Wang
YLYang Li
Yang Li